SI-BONE Inc. Releases Presentation Highlighting Strong Q2 2025 Financial Performance and Continued Growth
I'm PortAI, I can summarize articles.
SI-BONE Inc. has released its August 2025 Investor Presentation, showcasing a strong Q2 2025 performance with a 21.7% increase in worldwide revenue to $48.6 million and a 22.8% rise in U.S. revenue to $46.4 million. Key highlights include the launch of iFuse TORQ in Europe, a 25.0% growth in U.S. active physicians, an 80 basis point improvement in gross margin to 79.8%, and a positive adjusted EBITDA of $1.0 million. The company also generated $1.1 million in net cash.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments